Citadel Advisors - ULTRAGENYX PHARMACEUTICAL IN ownership

Back to all holdings Add to watchlist

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D908. A total of 3 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2016$514,000
-14.5%
10,500
+10.5%
0.00%0.0%
Q1 2016$601,000
+33.9%
9,500
+137.5%
0.00%–
Q4 2015$449,000
+10.9%
4,000
-4.8%
0.00%–
Q3 2015$405,000
+58.2%
4,200
+68.0%
0.00%–
Q2 2015$256,000–2,500–0.00%–
 Download
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 600$36,0000.00%
JANE STREET GROUP, LLC 6,100$364,0000.00%
SIMPLEX TRADING, LLC 300$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders